Showing results (41-50 of 51) with videos related to
Sort By:
Pageof 6
Cell Reports. Medicine|April 8, 2023
USP9X mediates an acute adaptive response to MAPK suppression in pancreatic cancer but creates multiple actionable therapeutic vulnerabilitiesNaiara Perurena, Rebecca Lock, Rachel A Davis, et al.Cancer Cell|July 4, 2009
Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesisLauren T McGillicuddy, Jody A Fromm, Pablo E Hollstein, et al.Cancer Research|May 20, 2004
Comparative pathology of nerve sheath tumors in mouse models and humansAnat O Stemmer-Rachamimov, David N Louis, Gunnlaugur P Nielsen, et al.Cell Reports|December 7, 2017
Melanoma Therapeutic Strategies that Select against Resistance by Exploiting MYC-Driven Evolutionary ConvergenceKatherine R Singleton, Lorin Crawford, Elizabeth Tsui, et al.American Journal of Medical Genetics. Part A|January 29, 2011
Back to the future: proceedings from the 2010 NF ConferenceSusan M Huson, Maria T Acosta, Allan J Belzberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2026
SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST)AeRang Kim, Karla V Ballman, Pamela L Wolters, et al.Cancer Discovery|August 9, 2024
Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal CancersPatrick Loi, Amy E Schade, Carrie L Rodriguez, et al.Nature|October 9, 2024
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involutionAmy E Schade, Naiara Perurena, Yoona Yang, et al.Cancer Discovery|June 18, 2016
Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung CancerHaikuo Zhang, Jun Qi, Jaime M Reyes, et al.Nature Genetics|August 14, 2019
Mutations in RABL3 alter KRAS prenylation and are associated with hereditary pancreatic cancerSahar Nissim, Ignaty Leshchiner, Joseph D Mancias, et al.Pageof 6